Table 1: In vitro antifungal susceptibility of <em>Candida auris</em> and Candida glabarta strains to Echinocandins and *Posaconazole.

Table 1: In vitro antifungal susceptibility of Candida auris and Candida glabarta strains to Echinocandins and *Posaconazole.

		Minimal Fungicidal Concentration (MFC) (μg/ml)			Inhibitory concentration (μg/ml)
Origin	C. auris strains	Caspofungin	Micafungin	Anidulafungin	Posaconazole	Caspofungin	Micafungin	Anidulafungin
		MFC	MFC	MFC	IC^*	IC_90%	IC_90%	IC_90%
Japan	CDC 0381	0.038	0.028	0.028	71%, 0.78	0.016	0.014	0.0135
South Asia	CDC 0382	> 32	0.028	0.032	64%, 0.78	> 32	0.014	0.02
South Africa	CDC 0383	> 32	> 32	> 32	60%, 0.39	> 32	> 32	> 32
South Africa	CDC 0384	> 32	> 32	> 32	61%, 0.78	> 32	> 32	> 32
Venezuala	CDC 0385	> 32	0.0625	0.0625	63%, 0.09	> 32	0.034	0.043
Venezuala	CDC 0386	> 32	0.125	0.0612	65%, 0.78	> 32	0.055	0.0335
Pakistan	CDC 0387	> 32	0.083	0.75	53%, 0.78	> 32	0.42	0.24
Pakistan	CDC 0388	> 32	0.0625	0.032	79%, 0.19	> 32	0.0145	0.027
South Asia	CDC 0389	> 32	0.032	0.032	70%, 0.19	> 32	0.016	0.024
South Asia	CDC 0390	> 32	0.028	0.028	67%, 0.097	0.14	0.014	0.0145
	C. glabrata 0317	> 32	0.03125	0.25	39% > 12.5	0.9	0.025	0.225
GM^#		> 32	0.056 ± 0.035	0.13 ± 0.25	0.49 ± 0.31	> 32	0.025 ± 0.016	0.05 ± 0.08
MIC₅₀		ND	0.028-0.032	0.028-0.032	0.09-0.39	ND	0.014-0.016	0.014-0.016
MIC₉₀		ND	0.125	0.75	0.78	ND	0.055	0.24
^**CLSI-MIC₅₀					0.016	ND	0.125	0.125
^**CLSI-MIC₉₀					0.125	ND	0.5	0.5

^*-Inhibition 53-79%, ^**-CLSI based tentative cutoff breakpoint of susceptibility for C. auris strains as reported by Arendrup, et al. 2017. ^#Geometric mean ± S.D. The values of the resistant strains (> 32 µg/ml, gray cell) are not included.